PRF Technologies (PRFX) Share-based Compensation (2019 - 2024)
PRF Technologies' (PRFX) quarterly Share-based Compensation came in at -$113000.0 in Q2 2024, down 143.3% on a YoY basis from $261000.0 in Q3 2023, and down 198.26% quarter-over-quarter from $115000.0 in Q1 2024.
Powered by 
Analysis
PRF Technologies (PRFX) Share-based Compensation (2019 - 2024) Analysis & Trends
PRF Technologies (PRFX) has reported Share-based Compensation for 6 consecutive years, with -$113000.0 the latest figure, recorded in Q2 2024.
- For the quarter ending Q2 2024, Share-based Compensation fell 143.3% year-over-year to -$113000.0; the trailing twelve-month figure through Jun 2024 stood at $365000.0 (down 73.93% YoY), and the FY2025 full-year result was $447000.0, up 44.19% from the prior year.
- Share-based Compensation retreated to -$113000.0 in Q2 2024 per PRFX's latest filing, from $115000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $736000.0 in Q4 2022 and bottomed at -$113000.0 in Q2 2024.
- Historically, Share-based Compensation has averaged $189914.2 across 5 years, with a median of $192500.0 in 2021.
- The sharpest annual moves came in 2021 and 2024: Share-based Compensation surged 2288.89% in 2021, then sank 143.3% in 2024.
- Over 5 years, Share-based Compensation stood at $167000.0 in 2020, then jumped by 37.72% to $230000.0 in 2021, then soared by 220.0% to $736000.0 in 2022, then slumped by 75.41% to $181000.0 in 2023, then slumped by 162.43% to -$113000.0 in 2024.
- According to Business Quant data, Share-based Compensation over the past three periods registered -$113000.0, $115000.0, and $181000.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn | 40.00 Mn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn | 30.40 Mn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn | 1.02 Mn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn | 176,000.00 |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn | 54.00 Mn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn | 11.41 Mn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn | 2.92 Mn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn | 29.30 Mn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn | 7.04 Mn |
| 10 | PRF Technologies | 622,054.07 | -10.31 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -113,000.00 |
| Mar 31, 2024 | 115,000.00 |
| Dec 31, 2023 | 181,000.00 |
| Sep 30, 2023 | 182,000.00 |
| Jun 30, 2023 | 261,000.00 |
| Mar 31, 2023 | 180,000.00 |
| Dec 31, 2022 | 736,000.00 |
| Sep 30, 2022 | 223,000.00 |
| Jun 30, 2022 | 220,000.00 |
| Mar 31, 2022 | 210,000.00 |
| Dec 31, 2021 | 230,000.00 |
| Sep 30, 2021 | 215,000.00 |
| Jun 30, 2021 | 203,000.00 |
| Mar 31, 2021 | 164,000.00 |
| Dec 31, 2020 | 167,000.00 |
| Sep 30, 2020 | 9,000.00 |
| Jun 30, 2020 | 219,456.00 |
| Mar 31, 2020 | 16,000.00 |
| Dec 31, 2019 | 219,456.00 |
API Access
PRF Technologies Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PRFX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "PRFX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PRFX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();